Compare BioNTech SE - ADR (BNTX) vs Vertiv Holdings Co (VRT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Vertiv Holdings Co — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Vertiv Holdings Co trades at $295.72 (market cap $108.49B). The key difference: Vertiv Holdings Co is far larger — about 4.7× BioNTech SE - ADR's market cap, and Vertiv Holdings Co pays a 0.09% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | VRT | |
|---|---|---|
Market Cap | $23.31B | $108.49B |
Sector | Health | Technology |
52-Week High | $119.34 | $376.23 |
52-Week Low | $83.89 | $121.82 |
Enterprise Value | $6.60B | $108.72B |
Dividend Yield | — | 0.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Vertiv Holdings Co
Vertiv is a global leader in critical digital infrastructure, providing essential power, cooling, and IT management solutions for data centers, communication networks, and industrial facilities. As the primary provider of advanced thermal management and liquid cooling systems, Vertiv is a central player in the AI revolution, enabling the extreme density and power requirements of next-generation GPU-driven computing.
Read more on VRT →
